Repligen Corporation (RGEN) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $176.89 (-0.73%), Market cap $6.39B, P/E ratio 124.58, 52-week low–high $102.87 ~ $172.26.
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and
Financial statements, price targets, institutional (13F) holdings and related news for Repligen Corporation are updated in real time on BlackAll Trade.
Repligen Corporation trades at $176.89 (-0.73%). Real-time quotes and charts are available on BlackAll Trade.
Repligen Corporation has a market cap of about $6.39B. Its P/E ratio is 124.58.
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's product